Related Experiment Videos
Additional bioactive Lyso-PAF congeners from the sponge Spirastrella abata.
Journal of Natural Products
|April 28, 2001
Summary
Researchers discovered five lyso-platelet activating factor (PAF) derivatives from the Spirastrella abata sponge. Two novel compounds feature a unique methoxy group, and all showed potential in cholesterol biosynthesis inhibition and cancer cell cytotoxicity.
Area of Science:
- Marine Natural Products Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Marine sponges are a rich source of bioactive compounds.
- Platelet-activating factor (PAF) and its analogs have diverse biological activities.
- Lyso-PAF derivatives are less explored but hold potential therapeutic value.
Purpose of the Study:
- To isolate and characterize novel lyso-PAF derivatives from the marine sponge Spirastrella abata.
- To investigate the structural features of these compounds, including unprecedented substitutions.
- To evaluate their biological activities, specifically cholesterol biosynthesis inhibition and cytotoxicity against human tumor cells.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation employing comprehensive spectroscopic methods (NMR, MS).
- In vitro assays for cholesterol biosynthesis inhibition and cytotoxicity screening.
Main Results:
- Isolation of one known and four new lyso-PAF derivatives (compounds 1-5).
- Identification of two unprecedented lyso-PAF derivatives with a C-2' methoxy group.
- Demonstration of inhibitory effects on cholesterol biosynthesis.
- Exhibition of cytotoxic activity against human solid tumor cell lines.
Conclusions:
- Spirastrella abata is a source of novel lyso-PAF derivatives with unique structural features.
- These compounds warrant further investigation for their therapeutic potential in cholesterol-related disorders and cancer.
- The C-2' methoxy group may confer unique biological properties.